Steve is the Chief Executive Officer of MediBeacon, a St. Louis-based medical device company. MediBeacon was formed after acquiring the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon’s mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Steve is an experienced global business leader who has managed highly complex pharmaceutical and medical device operations with annual global revenue exceeding $1 billion. As the President of Covidien’s Imaging Solutions business unit, he led a multifunctional organization that included sales, marketing, logistics, manufacturing, as well as research and development. Over his nearly 18 years with the Covidien family of companies, Steve developed a large network of business leaders and clinicians to help determine market needs, commercial potential and product positioning. As a sales leader, he called on radiologists, nuclear medicine physicians, cardiologists, as well as surgeons in specialties including general, orthopedic, and OB/GYN. Steve received an undergraduate business degree and MBA from Marquette University.